Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling-Reference-Cited by-同舟云学术

Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling

Published:2014-12 Issue: Volume:65 Page:156-166
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Bosgra Sieto,van de Steeg Evita,Vlaming Maria L.,Verhoeckx Kitty C.,Huisman Maarten T.,Verwei Miriam,Wortelboer Heleen M.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference56 articles.

1. Interactions between cyclosporin and lipid-lowering drugs, implications for organ transplant recipients;Asberg;Drugs,2003

2. Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase;Bergman;Eur. J. Pharm. Sci.,2006

3. Quantitative assessment of the contribution of sodium-dependent taurocholate co-transporting polypeptide (NTCP) to the hepatic uptake of rosuvastatin, pitavastatin and fluvastatin;Bi;Biopharm. Drug Dispos.,2013

4. Mammalian ABC transporters in health and disease;Borst;Annu. Rev. Biochem.,2002

5. An improved model to predict physiologically based model parameters and their inter-individual variability from anthropometry;Bosgra;Crit. Rev. Toxicol.,2012

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically Based Pharmacokinetic Model of OATP1B Substrates with a Nonlinear Mixed Effect Approach: Estimating Empirical In Vitro-to-In Vivo Scaling Factors;Clinical Pharmacokinetics;2024-08

2. Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins;CPT: Pharmacometrics & Systems Pharmacology;2024-04-04

3. The next frontier in ADME science: Predicting transporter-based drug disposition, tissue concentrations and drug-drug interactions in humans;Pharmacology & Therapeutics;2022-10

4. Human Hepatic Transporter Signature Peptides for Quantitative Targeted Absolute Proteomics: Selection, Digestion Efficiency, and Peptide Stability;Pharmaceutical Research;2022-09-21

5. Functional in vitro characterization of SLCO1B1 variants and simulation of the clinical pharmacokinetic impact of impaired OATP1B1 function.;European Journal of Pharmaceutical Sciences;2022-09